Skip to main content

Raquel Maria Lastra Borras

Institutions of which they are part

Research technician
Headache and Neurological Pain
Vall Hebron Institut de Recerca

Raquel Maria Lastra Borras

Institutions of which they are part

Research technician
Headache and Neurological Pain
Vall Hebron Institut de Recerca

Related news

The treatment with fremanezumab becomes the first approved therapy to demonstrate efficacy in children and adolescents, a key stage of life as it is one of the most disabling and concentrates the peak incidence of the disease.

Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research

Two international studies led by Vall d'Hebron recommend early administration of specific drugs to prevent migraine to achieve a better response to therapy.

Related professionals

Arnau Cortés Nuet

Arnau Cortés Nuet

Technological Infrastructure Unit
Digital Transformation Directorate
Read more
Rubén Martínez Jaen

Rubén Martínez Jaen

Clinical Trials Management Unit
Clinical Research Development Directorate
Read more
Sergio Aguilar Alegre

Sergio Aguilar Alegre

Research technician
Clinical Neuroimmunology
Read more
Manuel Jesus Iglesias Cabezas

Manuel Jesus Iglesias Cabezas

Predoctoral researcher
Microbiology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.